<code id='5AC2188C69'></code><style id='5AC2188C69'></style>
    • <acronym id='5AC2188C69'></acronym>
      <center id='5AC2188C69'><center id='5AC2188C69'><tfoot id='5AC2188C69'></tfoot></center><abbr id='5AC2188C69'><dir id='5AC2188C69'><tfoot id='5AC2188C69'></tfoot><noframes id='5AC2188C69'>

    • <optgroup id='5AC2188C69'><strike id='5AC2188C69'><sup id='5AC2188C69'></sup></strike><code id='5AC2188C69'></code></optgroup>
        1. <b id='5AC2188C69'><label id='5AC2188C69'><select id='5AC2188C69'><dt id='5AC2188C69'><span id='5AC2188C69'></span></dt></select></label></b><u id='5AC2188C69'></u>
          <i id='5AC2188C69'><strike id='5AC2188C69'><tt id='5AC2188C69'><pre id='5AC2188C69'></pre></tt></strike></i>

          Home / entertainment / explore

          explore


          explore

          author:Wikipedia    Page View:16727
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In